Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 445-453

  Ozkan, Gulsum ^a   Ulusoy, Sukru ^a   Orem, Asim ^a   Ersoz, Safak ^a   Alkanat, Mehmet ^a   Yucesan, Fulya Balaban ^a   Kaynar, Kubra ^a   Al, Sait ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Contrast mediated nephropathy; Grape seed proanthocyanidin; Grape seed proanthocyanidin extract; Malondialdehyde; Oxidative system

Indexed keywords

CONTRAST MEDIUM; CREATININE; GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDIN EXTRACT; MALONALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EDEMA; FEMALE; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY NECROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; GRAPE SEED EXTRACT; KIDNEY DISEASES; PLANT EXTRACTS; PROANTHOCYANIDINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84861793625     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000337926     Document Type: Article

References (32)

1. Morcos SK, Thomsen HS, Webb JA: Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999; 9: 1602-1613.
2. Itoh Y, Yano T, Sendo T, Oishi R: Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005; 97: 473-488.
3. Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C: Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010; 45: 188-195.
4. Bagchi D, Bagchi M, Stohs S, Ray SD, Sen CK, Preuss HG: Cellular protection with proanthocyanidins derived from grape seeds. Ann NY Acad Sci 2002; 957: 260-270.
5. Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, Vinson JA: Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003; 523: 87-97.
6. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ: Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997; 95: 179-189.
7. Colbay M, Yuksel S, Uslan I, Acarturk G, Karaman O, Bas O, Mollaoglu H, Yagmurca M, Ozen OA: Novel approach for the prevention of contrast nephropathy. Exp Toxicol Pathol 2010; 62: 81-89.
8. Uchiyama M, Mihara M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analyt Biochem 1978; 86: 271-278.
9. Harma M, Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563-566.
10. Heyman SN, Rosenberger C, Rosen S: Regional alterations in renal haemodynamics and oxygenation: A role in contrast mediuminduced nephropathy. Nephrol Dial Transplant 2005; 20: 6-11.
11. Sochman J, Peregrin JH, Bürgelová M, Kopkan L, Kramer HJ, Cervenka L: N-acetylcysteine attenuates iodine contrast agent-induced nephropathy in 5/6-nephrectomized rats. Kidney Blood Press Res 2010; 33: 149-156.
12. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV: Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-2842.
13. Mueller C: Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int 2006; 100: 16-19.
14. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB: Nephrotoxicity of ionic and nonionic contrast media in 1,196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261.
15. Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G: Contrast agents and renal cell apoptosis. Eur Heart J 2008; 29: 2569-2576.
16. Briguori C, Quintavalle C, De Micco F, Condorelli G: Nephrotoxicity of contrast media and protective effects of acetylcysteine. Arch Toxicol 2011; 85: 165-173.
17. Finn WF: The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 2006; 21: 2-10.
18. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004; 291: 2328-2334.
19. Wróbel W, Sinkiewicz W, Gordon M, Woźniak-Wiśniewska A: Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol 2010; 68: 1015-1012.
20. Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362: 598-603.
21. Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B: Standard vs. double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25: 206-211.
22. ACT Investigators: Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation 2011; 124: 1250-1259.
23. Ray SD, Patel D, Wong V, Bagchi D: In vivo protection of DNA damage-associated apoptotic and necrotic cell deaths during acetaminophen- induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol 2000; 107: 137-166.
24. Yousef MI, Saad AA, El-Shennawy LK: Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 2009; 47: 1176-1183.
25. Saad AA, Youssef MI, El-Shennawy LK: Cisplatin-induced damage in kidney genomic DNA and nephrotoxicity in male rats: The protective effect of grape seed proanthocyanidin extract. Food Chem Toxicol 2009; 47: 1499-1506.
26. Yanarates O, Guven A, Sizlan A, Uysal B, Akgul O, Atim A, Ozcan A, Korkmaz A, Kurt E: Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail 2008; 30: 931-938.
27. Safa J, Argani H, Bastani B, Nezami N, Rahimi Ardebili B, Ghorbanihaghjo A, Kalagheichi H, Amirfirouzi A, Mesgari M, Soleimany Rad J: Protective effect of grape seed extract on gentamicin-induced acute kidney injury. Iran J Kidney Dis 2010; 4: 285-291.
28. Ray SD, Kumar MA, Bagchi D: A novel proanthocyanidin IH636 grape seed extract increases in vivo Bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver. Arch Biochem Biophys 1999; 369: 42-58.
29. Sato M, Bagchi D, Tosaki A, Das DK: Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and CJUN. Free Radic Biol Med 2001; 31: 729-737.
30. Efrati S, Berman S, Ilgiyeav I, Siman-Tov Y, Averbukh Z, Weissgarten J: Differential effects of N-acetylcysteine, theophylline or bicarbonate on contrast-induced rat renal vasoconstriction. Am J Nephrol 2009; 29: 181-191.
31. Banerjee B, Bagchi D: Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion 2001; 63: 203-206.
32. Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D: Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J Med 2000; 31: 227-246.